MedDay, a Paris, France-based biotech company. Founded in 2011 by Dr Frédéric Sedel and Dr Guillaume Brion, MedDay specializes in the treatment of neuro-metabolic diseases. The company’s technology platform leverages the work of Dr Frédéric Sedel, a neuroscientist at La Pitié Salpêtrière Hospital (Paris), in the area of neuropsychiatric diseases. The company is currently incubated at l’Institut du Cerveau et de la Moelle épinière in Paris (ICM).
Sofinnova Partners is an independent venture capital firm based in Paris, France. For over 35...
26 R Des Rigoles